News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

|Articles|June 13, 2023

Transduction for AAV with Sean Hart

Author(s)Chris Spivey

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed here.

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

Colorful chain of amino acids or bio molecules called proteins - 3d illustration | Image credit: © Christoph Burgstedt - © Christoph Burgstedt - stock.adobe.com

Propanc Reports Scalable Yeast-Based Production of Recombinant Trypsinogen, Chymotrypsinogen for Backup Cancer Therapy

ByFeliza Mirasol

July 21st 2026

3D medical illustration of ovarian cancer. | Image Credit: © Sebastian Kaulitzki - stock.adobe.com

Imunon's IMNN-001 Overcomes Historical IL-12 Safety Barriers in Phase 2 MRD Ovarian Cancer Data

ByEmily Schoenthaler

July 21st 2026

Microbiological bioreactor. Cultivation of microorganisms. Bio-fermentation. Bioengineering. Vaccine production. Creation of medicines. Pharmacology. Laboratory equipment. | Image credit: © Grispb - © Grispb - stock.adobe.com

A Flexible Manufacturing and Workforce Modernization Q&A With Sebastián Arana

ByFeliza Mirasol,Sebastián Arana

July 20th 2026

Concept of EMA European Medicines Agency. Drugs evaluation and quality control department. | Image credit: © wladimir1804 - stock.adobe.com

EMA Review of Apitegromab in Spinal Muscular Atrophy Delayed Pending Manufacturing Inspection Outcome

ByFeliza Mirasol

July 20th 2026

3d rendered medically accurate illustration of the pancreas. | Image Credit: © Sebastian Kaulitzki - stock.adobe.com

Johns Hopkins-Developed KRAS Vaccine Shows Durable Immune Response in Pancreatic Cancer Prevention Trial

ByEmily Schoenthaler

July 17th 2026